Table 1 Summary of studies included (N = 24)

Study design

 Quantitative

22 (91.7)

 Cross-sectional

13 (54.2)

 Longitudinal

3 (12.5)

 Quasi-experimental

2 (8.3)

 Retrospective

4 (16.7)

 Mixed methods

2 (8.3)

Sample size

 None given

1 (4.2)

 1–100

7 (29.2)

 101–1000

10 (41.6)

 > 1000

6 (25.0)

Region (as defined by WHO)

 Africa

1 (4.2)

 Americas

11 (45.8)

 South-East Asia

1 (4.2)

 Europe

5 (20.8)

 Eastern Mediterranean

0 (0.0)

 Western Pacific

2 (8.3)

 Global

2 (8.3)

Respiratory epidemic

 COVID-19

24 (100)

Primary SRH outcome^a

 Abortion

8 (33.3)

 Contraceptive access/utilization

5 (20.8)

 Menstruation

2 (8.3)

 Service provision

6 (25.0)

 Sexual behavior

4 (16.7)

 Pregnancy intentions

3 (12.5)

QATSDD

 High

10 (41.7)

 Low

14 (58.3)